A Study of Selpercatinib After Surgery or Radiation in Participants With Non-Small Cell Lung Cancer (NSCLC)

~4 mi. (Bendigo, Australia, +172 more cities)

Bendigo Health

RET Fusion

Non-Small Cell Lung Carcinoma

selpercatinib

targeted therapy

Darolutamide Augments Standard Therapy for Localised Very High-Risk Cancer of the Prostate

~4 mi. (Bendigo, Australia, +46 more cities)

Peter MacCallum Cancer Centre - Bendigo Campus

Prostate Adenocarcinoma

darolutamide, +2 more drugs

hormone therapy, +1 more type

A Study of Relatlimab Plus Nivolumab in Combination With Chemotherapy vs. Nivolumab in Combination With Chemotherapy as First Line Treatment for Participants With Stage IV or Recurrent Non-small Cell Lung Cancer (NSCLC)

~4 mi. (Bendigo, Australia, +126 more cities)

Local Institution

Non-Small Cell Lung Carcinoma

nivolumab, +2 more drugs

chemotherapy, +1 more type

Study of Adjuvant Cemiplimab Versus Placebo After Surgery and Radiation Therapy in Patients With High Risk Cutaneous Squamous Cell Carcinoma

~4 mi. (Bendigo, Australia, +118 more cities)

Regeneron Research Site

Skin Squamous Cell Carcinoma

cemiplimab

immunotherapy

EXamining PErsonalised Radiation Therapy for Low-risk Early Breast Cancer

~4 mi. (Bendigo, Australia, +47 more cities)

Peter MacCallum Cancer Centre - Bendigo

ER Positive, +2 more biomarkers

Breast Carcinoma

hormone therapy

hormone therapy

A Phase 3 Efficacy, Safety and Tolerability Study of Zolbetuximab (Experimental Drug) Plus mFOLFOX6 Chemotherapy Compared to Placebo Plus mFOLFOX6 as Treatment for Gastric and Gastroesophageal Junction (GEJ) Cancer

~7 mi. (East Bendigo, Australia, +202 more cities)

Site AU61006

CLDN18 Expression, +1 more biomarker

Adenocarcinoma of the Gastroesophageal Junction, +1 more condition

modified FOLFOX6 regimen, +1 more drug

chemotherapy, +1 more type

A Study Evaluating the Efficacy and Safety of Adjuvant Giredestrant Compared With Physician's Choice of Adjuvant Endocrine Monotherapy in Participants With Estrogen Receptor-Positive, HER2-Negative Early Breast Cancer (lidERA Breast Cancer)

~75 mi. (Wendouree, Australia, +89 more cities)

Ballarat Oncology & Haematology

ER Positive, +1 more biomarker

Breast Carcinoma

giredestrant, +1 more drug

hormone therapy

RegoNivo vs Standard of Care Chemotherapy in AGOC

~75 mi. (Wendouree, Australia, +51 more cities)

Ballarat Oncology and Haematology Services

Adenocarcinoma of the Gastroesophageal Junction, +2 more conditions

nivolumab, +1 more drug

immunotherapy, +1 more type

A Study of Nivolumab or Placebo in Combination With Docetaxel in Men With Advanced Castration-resistant Prostate Cancer

~77 mi. (Ballarat, Australia, +271 more cities)

Ballarat Base Hospital

Prostate Adenocarcinoma

docetaxel, +2 more drugs

chemotherapy, +2 more types

A Study of Nivolumab and Ipilimumab in Untreated Participants With Stage 3 Non-small Cell Lung Cancer (NSCLC) That is Unable or Not Planned to be Removed by Surgery

~77 mi. (Ballarat, Australia, +174 more cities)

Ballarat Health Services-Medical Oncology

Non-Small Cell Lung Carcinoma

chemoradiotherapy, +3 more drugs

chemotherapy, +2 more types

A Study of Ociperlimab With Tislelizumab Compared to Pembrolizumab in Participants With Untreated Lung Cancer

~77 mi. (Ballarat, Australia, +160 more cities)

Ballarat Health Services

PD-L1 High Expression (TPS >= 50%)

Non-Squamous Non-Small Cell Lung Carcinoma, +1 more condition

ociperlimab, +1 more drug

immunotherapy

Placebo-controlled Study Comparing Niraparib Plus Pembrolizumab Versus Placebo Plus Pembrolizumab as Maintenance Therapy in Participants With Advanced/Metastatic Non-small Cell Lung Cancer

~77 mi. (Ballarat, Australia, +151 more cities)

GSK Investigational Site

Non-Small Cell Lung Carcinoma

niraparib, +1 more drug

immunotherapy, +1 more type